T. Yasuda

发表

Medium-term Influence of the Coronavirus Disease 2019 Pandemic on Patients with Diabetes: A Single-center Cross-sectional Study

Yumiko Maruo, Y. Irie, Y. Obata, 2021, Internal medicine.

High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study

I. Shimomura, T. Matsuoka, M. Matsuhisa, 2020, Journal of diabetes investigation.

Independent Risk Factors for Positive and Negative Symptoms in Patients with Diabetic Polyneuropathy

I. Shimomura, M. Shibata, M. Sumitani, 2016, Journal of pain & palliative care pharmacotherapy.

Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist.

T. Funahashi, I. Shimomura, H. Kaneto, 2016, Internal medicine.

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2021, Diabetes Therapy.

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

I. Shimomura, H. Kaneto, H. Yokoyama, 2020, Cardiovascular Diabetology.

Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Atherosclerosis.

Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.

I. Shimomura, H. Kaneto, M. Matsuhisa, 2013, Endocrine journal.

Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient.

I. Shimomura, H. Kaneto, T. Matsuoka, 2010, Diabetes research and clinical practice.

A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole

I. Shimomura, H. Kaneto, M. Matsuhisa, 2013, Case reports in endocrinology.

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance

T. Funahashi, I. Shimomura, H. Kaneto, 2012, Journal of diabetes investigation.

Coexistence of Renin-independent Aldosterone Secretion and Multiple Endocrine Neoplasia Type 1 Within a Family

Yumiko Maruo, Y. Obata, Kana Takayama, 2022, Journal of the Endocrine Society.

YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes research and clinical practice.

Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma

Y. Obata, Hiroki Yamaguchi, Motohiro Kosugi, 2020, Diabetology International.

Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Atherosclerosis.

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2009, Atherosclerosis.

Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes research and clinical practice.

PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells.

T. Miyatsuka, M. Hori, Y. Yamasaki, 2002, Diabetes.

Relationship Between Carotid Intima-Media Thickness and the Presence and Extent of Coronary Stenosis in Type 2 Diabetic Patients With Carotid Atherosclerosis but Without History of Coronary Artery Disease

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes Care.

Regular insulin, rather than rapid‐acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Journal of diabetes investigation.

Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes.

H. Kaneto, M. Matsuhisa, M. Hori, 2002, Diabetes research and clinical practice.

Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.

T. Funahashi, I. Shimomura, H. Kaneto, 2012, Internal medicine.

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients

I. Shimomura, T. Matsuoka, T. Yasuda, 2018, Journal of diabetes investigation.

Serum vitamin D levels are decreased in patients without remission of Graves’ disease

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Endocrine.

Basal insulin requirements after progesterone treatment in a type 1 diabetic pregnant woman.

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Internal medicine.

NAD (P) H oxidase p22 phox C242T polymorphism affects LDL particle size and insulin resistance in Japanese subjects.

M. Hori, Y. Yamasaki, T. Yasuda, 2002, Journal of atherosclerosis and thrombosis.

Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes.

I. Shimomura, H. Kaneto, T. Matsuoka, 2016, Diabetes research and clinical practice.

A case of glucocorticoid-induced diabetes in which the efficacy between sitagliptin and metformin was compared

T. Funahashi, I. Shimomura, H. Kaneto, 2016, Diabetology International.

Sequential introduction and dosage balance of defined transcription factors affect reprogramming efficiency from pancreatic duct cells into insulin-producing cells.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Biochemical and biophysical research communications.

Comparison of Platelet Aggregability in Japanese Type 2 Diabetic Patients With and Without Microalbuminuria

T. Yasuda, T. Ishizaki, T. Yasuda, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Dramatic Improvement of Subcutaneous Insulin Resistance with Nafamostat Ointment Treatment

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2008, Diabetes Care.

Metformin-associated Lactic Acidosis with Hypoglycemia during the COVID-19 Pandemic

Yumiko Maruo, Y. Irie, Y. Obata, 2022, Internal medicine.

An Impaired Awareness of Hypoglycemia Improved After Vitamin B12 Treatment in a Type 1 Diabetic Patient

I. Shimomura, K. Fukui, A. Imagawa, 2017, Internal medicine.

Protein Kinase C-dependent, CCAAT/Enhancer-binding Protein β-mediated Expression of Insulin-like Growth Factor I Gene*

M. Hori, Y. Yamasaki, T. Yasuda, 2002, The Journal of Biological Chemistry.

Aniridia with a heterozygous PAX6 mutation in which the pituitary function was partially impaired.

T. Funahashi, I. Shimomura, H. Kaneto, 2014, Internal medicine.

PAX6 mutation as a genetic factor common to aniridia and glucose intolerance.

Masatsugu Hori, Yoshimitsu Yamasaki, Yasuo Tano, 2002, Diabetes.

PAX 6 Mutation as a Genetic Factor Common to Aniridia and Glucose Intolerance

Masatsugu Hori, Yoshimitsu Yamasaki, Yasuo Tano, 2001 .

Identification of a Portable Repression Domain and an E1A-Responsive Activation Domain in Pax4: a Possible Role of Pax4 as a Transcriptional Repressor in the Pancreas

J. Miyazaki, H. Kaneto, T. Matsuoka, 1999, Molecular and Cellular Biology.

Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes

T. Matsuoka, M. Matsuhisa, T. Yasuda, 2019, PloS one.

Short‐ and long‐term effect of sitagliptin after near normalization of glycemic control with insulin in poorly controlled Japanese type 2 diabetic patients

I. Shimomura, H. Kaneto, M. Matsuhisa, 2013, Journal of diabetes investigation.

Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2008, Diabetes research and clinical practice.

Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes.

H. Kaneto, T. Matsuoka, T. Miyatsuka, 2007, Current molecular medicine.

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

H. Nomura, H. Yoshiji, M. Matsuda, 2021, Journal of Gastroenterology.

Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Diabetes research and clinical practice.

Role of Pim-1 in Smooth Muscle Cell Proliferation*

H. Kaneto, M. Matsuhisa, M. Hori, 2004, Journal of Biological Chemistry.

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity

T. Funahashi, I. Shimomura, S. Fukuda, 2013, Cardiovascular Diabetology.

Selective contribution of waist circumference reduction on the improvement of sleep-disordered breathing in patients hospitalized with type 2 diabetes mellitus.

T. Funahashi, Y. Matsuzawa, I. Shimomura, 2011, Internal medicine.

A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain

I. Shimomura, A. Nakae, M. Shibata, 2012, Case reports in medicine.

Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Endocrine.

Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump

I. Shimomura, H. Kaneto, T. Matsuoka, 2011, Diabetes Care.

Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients

H. Kaneto, T. Matsuoka, M. Matsuhisa, 2008, Diabetes & vascular disease research.

Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2007, Endocrine journal.

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation

T. Funahashi, I. Shimomura, S. Fukuda, 2015, Cardiovascular Diabetology.

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study

I. Shimomura, H. Kaneto, H. Yokoyama, 2017, Diabetes Therapy.

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

I. Shimomura, H. Kaneto, H. Yokoyama, 2021, Cardiovascular Diabetology.

Predictive factors for the efficacy of switch to oral hypoglycemic agents in Japanese type 2 diabetic patients with intensive insulin therapy temporarily introduced.

I. Shimomura, H. Kaneto, T. Matsuoka, 2014, Endocrine journal.

A low serum IGF-1 is correlated with sarcopenia in subjects with type 1 diabetes mellitus: Findings from a post-hoc analysis of the iDIAMOND study.

I. Shimomura, M. Matsuhisa, Y. Irie, 2021, Diabetes research and clinical practice.

Painful Diabetic Neuropathy in Japanese Diabetic Patients Is Common but Underrecognized

I. Shimomura, M. Shibata, H. Kaneto, 2013, Pain research and treatment.

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

T. Funahashi, I. Shimomura, A. Imagawa, 2012, Cardiovascular Diabetology.

Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies

I. Shimomura, T. Matsuoka, Y. Irie, 2018, Journal of atherosclerosis and thrombosis.

Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients.

I. Shimomura, H. Kaneto, T. Matsuoka, 2013, Diabetes Research and Clinical Practice.

Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.

I. Shimomura, H. Kaneto, T. Matsuoka, 2012, Diabetes Technology & Therapeutics.

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

I. Shimomura, H. Kaneto, T. Matsuoka, 2023, Cardiovascular Diabetology.

Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency

Y. Obata, Kana Takayama, Hiroki Yamaguchi, 2021, Internal medicine.

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period

I. Shimomura, T. Matsuoka, T. Yasuda, 2019, Journal of Diabetes Investigation.

Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy

Yumiko Maruo, Y. Obata, Kana Takayama, 2022, Diabetology International.

Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes

I. Shimomura, T. Yasuda, H. Watada, 2021, Cardiovascular Diabetology.

Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated

I. Shimomura, H. Kaneto, T. Matsuoka, 2015, Journal of Diabetes Investigation.

Combined pituitary hormone deficiency harboring CHD7 gene missense mutation without CHARGE syndrome: a case report

Yumiko Maruo, Y. Obata, Kana Takayama, 2023, BMC Endocrine Disorders.

Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice

I. Shimomura, H. Kaneto, T. Matsuoka, 2015, Diabetologia.

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study

I. Shimomura, H. Kaneto, T. Yasuda, 2023, Scientific reports.

O R I G I N a L I N V E S T I G a T I O N Open Access Vascular Complications and Changes in Body Mass Index in Japanese Type 2 Diabetic Patients with Abdominal Obesity

T. Funahashi, I. Shimomura, S. Fukuda, 2022 .

Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?

H. Kaneto, M. Matsuhisa, Y. Yamasaki, 2007, Endocrine journal.